Cummings Keith Lamont 4
4 · PLIANT THERAPEUTICS, INC. · Filed Jul 11, 2024
Insider Transaction Report
Form 4
Cummings Keith Lamont
Chief Financial Officer
Transactions
- Award
Common Stock
2024-07-09+21,313→ 293,026 total
Footnotes (1)
- [F1]On July 28, 2022, the Reporting Person was granted 77,500 performance-vested stock units, the vesting of which were subject to the achievement of various pre-established performance criteria. On July 9, 2024, the Compensation Committee of the Issuer's Board of Directors certified the achievement of the performance criteria tied to the company's total shareholder return relative to the Nasdaq Biotechnology Index, resulting in the vesting of 21,313 shares.